Use of thymulin-like peptides for making pain-relieving medicines
US7309690B2 · kind B2 · utility
6Cited by
5References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 8, 2002 |
| Grant date | Dec 18, 2007 |
| Priority date | — |
| Expiry date | Mar 14, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the utilization of peptide analogues of thymulin that are inactive relative to the immune system, not comprising zinc and having anti-pain activity, for manufacturing a medicine for the treatment of pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.